144 related articles for article (PubMed ID: 37863739)
1. The ARTS (Avoiding Risks of Thrombosis and Bleeding in Surgery) Trial: Lessons Learnt in Setting Up an International Multicentre Clinical Trial of an Investigational Medicinal Product in the UK.
Ng A; Asif A; Keane K; Ippoliti S; Nathan A; Kasivisvanathan V;
Eur Urol Focus; 2023 Sep; 9(5):695-697. PubMed ID: 37863739
[TBL] [Abstract][Full Text] [Related]
2. Typical investigational medicinal products follow relatively uniform regulations in 10 European Clinical Research Infrastructures Network (ECRIN) countries.
Gluud C; Kubiak C; Whitfield K; Byrne J; Huemer KH; Thirstrup S; Libersa C; Barraud B; Grählert X; Dreier G; Geismann S; Kuchinke W; Temesvari Z; Blasko G; Kardos G; O'Brien T; Cooney M; Gaynor S; Schieppati A; de Andres F; Sanz N; Kreis G; Asker-Hagelberg C; Johansson H; Bourne S; Asghar A; Husson JM; Demotes-Mainard J
Trials; 2012 Mar; 13():27. PubMed ID: 22452964
[TBL] [Abstract][Full Text] [Related]
3. Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs.
Hata T; Nakamura K; Yonemori K; Noguchi E; Watanabe M; Sohn J; Lu YS; Yap YS; Tamura K; Fujiwara Y
Clin Transl Sci; 2021 May; 14(3):1015-1025. PubMed ID: 33382914
[TBL] [Abstract][Full Text] [Related]
4. Experience of conducting clinical trials of investigational medicinal products during a respiratory virus pandemic: Lessons learnt from COVID-19.
Burns JE; Carlin FE
Clin Trials; 2021 Apr; 18(2):260-262. PubMed ID: 33231098
[No Abstract] [Full Text] [Related]
5. International Society of Thrombosis and Hemostasis--XIXth Congress 12-18 July 2003, Birmingham, UK.
Shah S
IDrugs; 2003 Sep; 6(9):858-61. PubMed ID: 14565174
[No Abstract] [Full Text] [Related]
6. Review of new regulations for the conduct of clinical trials of investigational medicinal products.
Bollapragada SS; Norrie JD; Norman JE
BJOG; 2007 Aug; 114(8):917-21. PubMed ID: 17635485
[TBL] [Abstract][Full Text] [Related]
7. Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results.
Hwang TJ; Carpenter D; Lauffenburger JC; Wang B; Franklin JM; Kesselheim AS
JAMA Intern Med; 2016 Dec; 176(12):1826-1833. PubMed ID: 27723879
[TBL] [Abstract][Full Text] [Related]
8. Setting up non-commercial clinical trials takes too long in the UK: findings from a prospective study.
Hackshaw A; Farrant H; Bulley S; Seckl MJ; Ledermann JA
J R Soc Med; 2008 Jun; 101(6):299-304. PubMed ID: 18515777
[TBL] [Abstract][Full Text] [Related]
9. The tribulation of trials.
Healy B
US News World Rep; 2006 Apr; 140(12):66. PubMed ID: 16584055
[No Abstract] [Full Text] [Related]
10. Investigational medications and healthcare professional safety: A call for clinical trial sponsors to improve investigational product shipment labelling.
Jaskowiak JM; Chu B
Am J Health Syst Pharm; 2023 Jul; 80(15):960-961. PubMed ID: 36455874
[No Abstract] [Full Text] [Related]
11. Planning an Academic Clinical Trial.
Champion KM; Jones GR
Methods Mol Biol; 2015; 1317():287-313. PubMed ID: 26072413
[TBL] [Abstract][Full Text] [Related]
12. SOP 06: Selecting the participating centers and activation of a trial.
Onkologie; 2003 Oct; 26 Suppl 6():34-5. PubMed ID: 23570182
[No Abstract] [Full Text] [Related]
13. PCMO L01-Setting Specifications for Biological Investigational Medicinal Products.
Krause SO
PDA J Pharm Sci Technol; 2015; 69(5):569-89. PubMed ID: 26429107
[TBL] [Abstract][Full Text] [Related]
14. Non-commercial clinical trials of a medicinal product: can they survive the current process of research approvals in the UK?
Sheard L; Tompkins CN; Wright NM; Adams CE
J Med Ethics; 2006 Jul; 32(7):430-4. PubMed ID: 16816046
[TBL] [Abstract][Full Text] [Related]
15. [Initiation of clinical multicentre studies with local radiotracer production - Regulatory environment and radiopharmaceutical-organisational aspects].
Zippel C; Neels OC; Hennrich U; Giesel FL; Kopka K
Nuklearmedizin; 2019 Mar; 58(2):77-85. PubMed ID: 30917396
[TBL] [Abstract][Full Text] [Related]
16. Practical risk management in early phase clinical trials.
Coates S; Täubel J; Lorch U
Eur J Clin Pharmacol; 2019 Apr; 75(4):483-496. PubMed ID: 30569285
[TBL] [Abstract][Full Text] [Related]
17. British rethinking test rules after drug trial nearly kills 6.
Rosenthal E
N Y Times Web; 2006 Apr; ():A1, A6. PubMed ID: 16642579
[No Abstract] [Full Text] [Related]
18. Experimental drug that injured UK volunteers resumes in human trials.
Dyer O
BMJ; 2015 Apr; 350():h1831. PubMed ID: 25838401
[No Abstract] [Full Text] [Related]
19. The Age of BLood Evaluation (ABLE) randomised controlled trial: description of the UK-funded arm of the international trial, the UK cost-utility analysis and secondary analyses exploring factors associated with health-related quality of life and health-care costs during the 12-month follow-up.
Walsh TS; Stanworth S; Boyd J; Hope D; Hemmatapour S; Burrows H; Campbell H; Pizzo E; Swart N; Morris S
Health Technol Assess; 2017 Oct; 21(62):1-118. PubMed ID: 29067906
[TBL] [Abstract][Full Text] [Related]
20. Causality Assessment in Premarketing Drug Clinical Trials: Regulatory Evolution in the USA and Ongoing Concerns.
Goldman SA
Drug Saf; 2016 Oct; 39(10):895-901. PubMed ID: 27473417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
